Herbert Timothy P.'s Form 4/A amendment
AmendedInspire Medical Systems, Inc. (INSP) · filed Mar 13, 2023
- Accession no.
- 0001104659-23-031814
- Filed
- Mar 13, 2023
- Trade date
- Mar 17, 2022
- Filing delay
- 361 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Mar 21, 2022
This filing lists 4 non-derivative transactions. Open-market sales total $4.51M. It was filed 361 days after the trade.
This amendment replaces 0001104659-22-036197 (filed Mar 21, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Herbert Timothy P.CIK 0001737136 | Director, Officer (CEO and President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2022 | Common Stock | SSaleDisposed | −18,731 | $225.35F2 | −$4,221,030.85 | 114,790 | Direct | |
| Mar 17, 2022 | Common Stock | SSaleDisposed | −40 | $226.04 | −$9,041.6 | 114,790 | Direct | |
| Mar 17, 2022 | Common Stock | SSaleDisposed | −1,193 | $226.13F4 | −$269,773.09 | 118,778 | Indirect | |
| Mar 17, 2022 | Common Stock | SSaleDisposed | −36 | $227.53F7 | −$8,191.08 | 118,742 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This Form 4 amends and restates the previously reported sale transactions made by the Reporting Person that occurred on March 17, 2022 in order to reallocate such sales between the Reporting Person and a trust that is considered beneficially owned by the Reporting Person.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.00 to $225.995. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F3
The amount of securities listed in Column 5 reflects the total shares held following the transaction owned by the Reporting Person, by reference to the total reported in the Reporting Person's Form 4 filed on March 13, 2023. The total has increased from such Form 4 as a result of the prior overstatement of the sale of shares directly held by the Reporting Person on March 17, 2022 by 1,229 shares, which is corrected herein.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.04 to $226.65. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F5
The amount of securities listed in Column 5 reflects the total shares held following the transaction based on the total reported in the Reporting Person's most recent Form 4, dated March 13, 2023.
- F6
Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.515 to $227.58. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.